Merida Capital Partners is a private equity fund targeting fundamental growth drivers underpinning the rapid development of the legal cannabis industry. Merida's investment thesis focuses on products and services associated with the evolution of cannabis as an agricultural product, a natural plant-based medicine, a constituent in pharmaceutical formulations, and an adult use consumer product.Members of the Merida Capital Partners executive team have been working with state legal cannabis companies since 2009 and investing in cannabis related companies since 2012. The Partners have honed their investment philosophy through immersion in the most complex areas of the cannabis industry, the state regulated licensing process for medical cultivation and cannabis-based pharmaceutical development. The team has competed for and has been awarded the limited licenses in two of the strictest medical-only states in the United States, successes built from decades of experience in traditional industries of technology, real estate, structured finance and commercial and investment banking. While Merida has deep experience in the entire cannabis supply chain, our investment emphasis is grounded primarily in four distinct verticals: (i) medical cultivation, (ii) cultivation infrastructure; (iii) data and technology services; and (iv) pharmaceutical development and life sciences. Along with limited- license medical cultivators, we seek compelling long term value as the industry matures by investing in well-managed, revenue generating companies which offer cannabis-based businesses essential products or services. www.meridacap.com